Results 21 to 30 of about 59,797 (283)

Clinical Aspects and Management of Levodopa-Induced Dyskinesia

open access: yesParkinson's Disease, 2012
In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias.
Nicola Tambasco   +7 more
doaj   +1 more source

The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke [PDF]

open access: yes, 2012
Hemispatial neglect following right-hemisphere stroke is a common and disabling disorder, for which there is currently no effective pharmacological treatment. Dopamine agonists have been shown to play a role in selective attention and working memory, two
Kulinskaya, Elena   +26 more
core   +1 more source

Dopamine agonists in prolactinomas

open access: yesEndocrinology Research and Practice, 2022
-
Annamaria Colao
doaj   +2 more sources

A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease.

open access: yesPLoS ONE, 2019
Schizophrenia and Parkinson's disease can be controlled with dopamine antagonists and agonists. In order to improve the understanding of the reaction mechanism of these drugs, in this investigation we present a quantum chemical study of 20 antagonists ...
Ana Martínez   +2 more
doaj   +1 more source

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia

open access: yesFrontiers in Pharmacology, 2020
Dopamine receptors are widely distributed within the brain where they play critical modulator roles on motor functions, motivation and drive, as well as cognition.
Jean Claude Martel   +1 more
doaj   +1 more source

Effects of L-Dopa and Dopamine D2 Agonists on Recollection and Familiarity in Idiopathic Nondementing Parkinson’s Disease [PDF]

open access: yes, 2011
Idiopathic nondementing Parkinson’s disease (PD) is marked by progressive loss of dopaminergic neurons in the substantia nigra pars compacta and ventral tegmental area.
Edelstyn
core   +1 more source

Treatment of hyperprolactinemia: a systematic review and meta-analysis

open access: yesSystematic Reviews, 2012
Background Hyperprolactinemia is a common endocrine disorder that can be associated with significant morbidity. We conducted a systematic review and meta-analyses of outcomes of hyperprolactinemic patients, including microadenomas and macroadenomas, to ...
Wang Amy T   +14 more
doaj   +1 more source

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2021
Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine.
Lakshmi P. Menon MD, Wedad Rahman MD
doaj   +1 more source

Pharmacology of novel psychoactive substances [PDF]

open access: yes, 2016
This PhD work consists of an in vitro and in vivo part. In the in vivo part, we investigated the role of dopamine in the acute clinical effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in healthy human subjects.
Rickli, Anna
core   +1 more source

Progress in the study of Dopamine Receptor Agonists for Brain Protection after Ischemic Brain Injury

open access: yesZhongguo cuzhong zazhi
: Ischemic brain injury comprises 87% of all brain injuries and typically results in severe functional impairments. Dopamine, the most abundant catecholamine neurotransmitter in the brain, is intimately linked with autonomous movement, emotion, sleep ...
ZHANG Linyao1, LIU Lixu1,2
doaj   +1 more source

Home - About - Disclaimer - Privacy